This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. rose 7.9% to $5.86 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.1% to 16,724.46 and the Dow Jones Industrial Average rising 1.6% to 40,212.71.
Novavax Inc. closed 75.4% below its 52-week high of $23.86, which the company achieved on June 6th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 2.0% to $151.73, Pfizer Inc. rose 1.5% to $21.91, and Merck & Co. Inc. rose 2.10% to $79.18.
Trading volume totaled 6.6 million, compared to the 50-day average of 4.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 11, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。